Article Information
History
- September 14, 2019.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Tingting Wang1,*,
- JN Rashida Gnanaprakasam1,*,
- Xuyong Chen1,
- Siwen Kang1,
- Xuequn Xu1,
- Hua Sun3,
- Lingling Liu1,
- Ethan Miller1,
- Teresa A. Cassel2,
- Qiushi Sun2,
- Sara Vicente-Muñoz2,
- Marc O. Warmoes2,
- Andrew N. Lane2,
- Xiaotong Song3,4,$,
- Teresa W.-M. Fan2,$ and
- Ruoning Wang1,$
- 1Center for Childhood Cancer & Blood Diseases, Hematology/Oncology & BMT, Abigail Wexner Research Institute at Nationwide Children’s Hospital, The Ohio State University, Columbus, OH, USA
- 2Center for Environmental and Systems Biochemistry, Dept. of Toxicology and Cancer Biology, Markey Cancer Center, University of Kentucky, Lexington, KY 40536, USA
- 3The Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX 77030 USA
- 4Icell Kealex Therapeutics, Houston, TX 77021
- ↵$Correspondence should be addressed to: Ruoning Wang, Phone: 614-335-2980; Fax: 614-722-5895. ruoning.wang{at}nationwidechildrens.org; Teresa W.-M. Fan, Phone: 858-218-1028, Fax: 859-257-1307, twmfan{at}gmail.com; Xiaotong Song; shautong.song{at}icellkealex.com;
↵* Wang T and Gnanaprakasam J contributed equally to this paper
Posted September 14, 2019.
Inosine is an alternative carbon supply that supports effector T cell proliferation and antitumor function under glucose restriction
